22
Participants
Start Date
February 1, 1999
Primary Completion Date
October 17, 2000
Study Completion Date
September 22, 2008
ISIS 5132
4mg/kg/day IV for 21 days every 4 weeks.
Memorial Sloan-Kettering Cancer Center, New York
Duluth Clinic, Duluth
Cross Cancer Institute, Edmonton
Lethbridge Cancer Clinic, Lethbridge
Burnaby Hospital Regional Cancer Centre, Burnaby
Penticton Regional Hospital, Penticton
British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey
Prostate Centre at Vancouver General Hospital, Vancouver
BC Cancer Agency, Vancouver
St. Paul's Hospital - Vancouver, Vancouver
British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria
CancerCare Manitoba, Winnipeg
Moncton Hospital, Moncton
Doctor Leon Richard Oncology Centre, Moncton
Saint John Regional Hospital, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
Nova Scotia Cancer Centre, Halifax
Queen Elizabeth II Health Science Center, Halifax
Royal Victoria Hospital, Barrie, Barrie
Peel Memorial Hospital, Brampton
Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
Cancer Care Ontario-London Regional Cancer Centre, London
Trillium Health Centre, Mississauga
Credit Valley Hospital, Mississauga
York County Hospital, Newmarket
North York General Hospital, Ontario, North York
Lakeridge Health Oshawa, Oshawa
Ottawa Regional Cancer Center - General Division, Ottawa
Ottawa Regional Cancer Centre - Civic Campus, Ottawa
Peterborough Oncology Clinic, Peterborough
Algoma District Medical Group, Sault Ste. Marie
Scarborough Hospital - General Site, Scarborough Village
Hotel Dieu Hospital - St. Catharines, St. Catharines
Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay
Toronto East General Hospital, Toronto
Toronto Sunnybrook Regional Cancer Centre, Toronto
St. Michael's Hospital - Toronto, Toronto
Mount Sinai Hospital - Toronto, Toronto
Toronto General Hospital, Toronto
Princess Margaret Hospital, Toronto
Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto
Saint Joseph's Health Centre - Toronto, Toronto
Humber River Regional Hospital, Weston
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
Queen Elizabeth Hospital, PEI, Charlottetown
Centre Universitaire de Sante de l'Estrie, Fleurimont
Centre Hospitalier Regional de Lanaudiere, Joliette
Maisonneuve-Rosemont Hospital, Montreal
McGill University Department of Oncology, Montreal
Hotel Dieu de Montreal, Montreal
Centre Hospitalier de l'Universite de Montreal, Montreal
Centre Hospitalier de l'Universite' de Montreal - Pavillon Saint-Luc, Montreal, Montreal
Royal Victoria Hospital - Montreal, Montreal
Montreal General Hospital, Montreal
St. Mary's Hospital Center, Montreal
Queen Elizabeth Hospital, Montreal, Montreal
Hopital Du Sacre-Coeur de Montreal, Montreal
Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Québec
Hopital du Saint-Sacrament, Quebec, Québec
Hopital du Haut-Richelieu, Saint-Jean-sur-Richelieu
Hopital Laval, Ste-Foy
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Royal South Hants Hospital, Southampton
Lead Sponsor
NCIC Clinical Trials Group
NETWORK